• Home
  • About us
  • Services
  • Products
  • Media
  • Contact
  • Press releases
  • Meet us at
  • Publications
  • Presentation
24 Apr 2012

Bioceros Announces Expansion of its Service Portfolio to include BioWa POTELLIGENT® Cells

02 May 2011

Bioceros announces expansion of the Research License Agreement with Crucell STAR® Technology.

17 Feb 2011

Bioceros B.V. announces change of ownership.

12 Jan 2011

Bioceros awarded Eurostars grant.

07 Sep 2010

Prima BioMed and Bioceros announce licensing agreement for Cripto- 1 cancer immunotherapy treatment.

03 Aug 2009

Bioceros appoints Mark Treherne as chairman of the Supervisory Board.

10 Feb 2009

DSM and Crucell Sign Agreement with Bioceros to Serve as Pre- Approved Cell Line Generation Partner.

12 Sep 2008

Bioceros B.V. closes first financing round

20 May 2008

Crucell announces research license agreement with Bioceros on STAR technology

08 Jan 2008

Bioceros announces license option agreement with MaimoniDex RA for antibodies to be used for treatment of rheumatoid arthritis.

02 Jul 2007

Dr. Bram Bout joints Bioceros accompanied by a restructuring of the management structure.

01 May 2007

Co-operation of Bioceros and CELLution on process development in disposable bioreactors

02 Apr 2007

Profibrix to enter in a research collaboration with Bioceros

Press releases

  1. 24 Apr 2012

    Bioceros Announces Expansion of its Service Portfolio to include BioWa POTELLIGENT® Cells

  2. 02 May 2011

    Bioceros announces expansion of the Research License Agreement with Crucell STAR® Technology.

  3. 17 Feb 2011

    Bioceros B.V. announces change of ownership.

  4. 12 Jan 2011

    Bioceros awarded Eurostars grant.

Meet us at

  1. 18 Jun 2012

    Who: R. Brandt, J. Bia
    What: BIO 2012
    Where: Boston, USA

  2. 27 Jun 2012

    Who: Dr. B. Bout (speaker)
    What: Single Use Technologies - Bioprocessing & Stem Cells Europe
    Where: Dexter House, London, UK

     

Publications

  1. 23 Apr 2012

    CD4+ T cell vaccination overcomes defective cross-presentation of fungal antigens in a mousemodel of chronic granulomatous disease.

  2. 28 Mar 2012

    Sialylation of Campylobacter jejuni Lipo-Oligosaccharides: Impact on Phagocytosis and Cytokine Production in Mice.

  3. 13 Feb 2012

    Expression and Function of Transforming Growth Factor β in Melioidosis.

Bioceros B.V.

Remco M. Brandt
Yalelaan 46
3584 CM Utrecht
The Netherlands

About us

  • Management
  • Supervisory board
  • Business development
  • LinkedIn

Services

  • Monoclonal antibody generation
  • Cell line & process development
  • Immunoassay development

Media

  • Press releases
  • Meet us at
  • Publications
  • Presentation
  • Products
  • Contact
  • Route
  • Careers
  • Disclaimer
  • Login